Telemonitoring of Uncontrolled Hypertension

NCT02730052 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2019-02-01

No results posted yet for this study

Summary

The proportion of hypertensive patients achieving adequate blood pressure control meeting guideline targets remains low. Of those patients on blood pressure lowering drugs, only 50% reach control.

Objectives:

1. Test the feasibility of telemonitoring of blood pressure in uncontrolled hypertensive patients.
2. Investigate whether telemonitoring enabled self-measurement of blood pressure leads to faster blood pressure control than self-measurement without telemonitoring.
3. Secondary endpoints include adverse effects, assessment of quality of life, adherence, a log of technical problems, and cost-effectiveness.

Methods:

Randomised parallel-group study consisting of 4 stages.

* Screening to check for eligibility.
* Randomisation in a 1:1 proportion to control or experimental arm: In the control arm, doctors will receive reports on the self-measured blood pressure based on diary cards; in the experimental group, doctors will receive weekly reports via telemonitoring.
* Treatment period: Doctors will adjust treatment according to the present guidelines of Hypertension. Blood pressure control is a home blood pressure below 135 mm Hg systolic and 85 mm Hg diastolic. Once blood pressure control is achieved the treatment period ends.
* Late follow-up: Assessment of blood pressure control at home 3 months after completion of the treatment period by means of telemonitoring.

Sample size: 120 patients per group. Patients: recruited at clinics from Uruguay and Argentina.

Main Inclusion Criteria:

* Women and men, age range 20 to 80 years.
* Uncontrolled hypertension and new diagnosed hypertension with a self-measured blood pressure at home of 135 mm Hg systolic and/or 85 mm Hg diastolic or more;
* Patients should be willing to accept adherence checking during follow-up and sign an informed written consent.

Exclusion Criteria

* Patients emotionally or intellectually not capable of measuring their blood pressure at home;
* A clinical or social context, which is suboptimal for the self-measurement of blood pressure;
* Pregnancy;
* Alcohol or substance abuse or psychiatric illnesses;
* Participation in another study. Expected outcomes: blood pressure control will be achieved faster in the telemonitoring group.

Conditions

Interventions

DEVICE

Omron 9200T plus Telemonitoring

Telemonitoring of the self-measured blood pressure at home. After each blood pressure measurement the values are transmitted to and stored into a central station where a condensed weekly report is elaborated and delivered to the doctor (investigator).

DEVICE

Omron 9200T without Telemonitoring

Self-measured blood pressure at home and register the values in a diary card. Participants will perform 2 consecutive blood pressure measurements twice a day for a 7 day period, previous to the visit to the doctor's (investigator) office.

Sponsors & Collaborators

  • Hospital Italiano de Buenos Aires

    collaborator OTHER
  • KU Leuven

    collaborator OTHER
  • Universidad de la Republica

    lead OTHER

Principal Investigators

  • Jose G Boggia, MD PhD · Universidad de la Republica - Uruguay

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-12-31
Primary Completion
2019-06-30
Completion
2019-12-31

Countries

  • Argentina
  • Uruguay

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02730052 on ClinicalTrials.gov